Byotrol plc
("Byotrol" or the "Company")
Result of Annual General Meeting ("AGM")
Byotrol plc (AIM: BYOT), the developer of anti-microbial hygiene technologies, announces that all resolutions proposed at the AGM held earlier today, as set out in the Notice of Annual General Meeting, were duly passed.
The total proxy votes cast prior to the AGM were as follows:
| Resolution | In favour | | Against | | Withheld * |
| | Votes | % | Votes | % | Votes |
| | | | | | |
| | |
| | | |
| 1 | 86,451,264 | 100.00% | 0 | 0.00% | 43,999 |
| 2 | 84,563,912 | 97.78% | 1,920,652 | 2.22% | 10,699 |
| 3 | 84,563,912 | 97.78% | 1,920,652 | 2.22% | 10,699 |
| 4 | 86,451,264 | 99.96% | 33,300 | 0.04% | 10,699 |
| 5 | 83,979,088 | 97.10% | 2,505,476 | 2.90% | 10,699 |
| 6 | 83,978,338 | 97.10% | 2,506,226 | 2.90% | 10,699 |
| 7 | 86,449,571 | 99.96% | 34,993 | 0.04% | 10,699 |
| | |
| | | |
*A vote withheld is not a vote in law and is therefore not counted towards the proportion of votes "in favour" or "against" the resolutions.
Enquiries:
| Byotrol Plc | |
| David Traynor - Chief Executive Officer | +44 (0)1925 742 000 |
| Chris Sedwell - Chief Financial Officer | |
| | |
| finnCap Limited (Nominated Adviser and Broker) | +44 (0)20 7220 0500 |
| Geoff Nash / James Thompson - Corporate Finance | |
| Richard Chambers - ECM | |
| | |
| Flagstaff Strategic and Investor Communications | +44 (0)20 7129 1474 |
| Tim Thompson/Andrea Seymour/Fergus Mellon
|
|
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a leading infection prevention and control company, operating globally in the animal health, human health, facilities management, and consumer sectors.
Byotrol develops unique antimicrobial technologies for use on surfaces, skin and instruments, which it then commercialises through market-leading distribution partners in each sector.
Byotrol's antimicrobial technologies can be licensed for use in leading brands, to significantly improve their product claims, while reassuring consumers and end-users of their efficacy and quality.
Founded in 2005, the Company develops technologies and products with the aim of providing easier, safer and cleaner lives for everyone.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.